- Home
- EVOK vs SOBR Comparison
EVOK vs SOBR Comparison
Compare EVOK & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- SOBR
- Stock Information
- Founded
- EVOK 2007
- SOBR 2004
- Country
- EVOK United States
- SOBR United States
- Employees
- EVOK N/A
- SOBR N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- SOBR Newspapers/Magazines
- Sector
- EVOK Health Care
- SOBR Consumer Discretionary
- Exchange
- EVOK Nasdaq
- SOBR Nasdaq
- Market Cap
- EVOK 5.4M
- SOBR 4.9M
- IPO Year
- EVOK 2013
- SOBR N/A
- Fundamental
- Price
- EVOK $5.12
- SOBR $3.23
- Analyst Decision
- EVOK
- SOBR
- Analyst Count
- EVOK 0
- SOBR 0
- Target Price
- EVOK N/A
- SOBR N/A
- AVG Volume (30 Days)
- EVOK 432.5K
- SOBR 14.7K
- Earning Date
- EVOK 11-06-2025
- SOBR 11-13-2025
- Dividend Yield
- EVOK N/A
- SOBR N/A
- EPS Growth
- EVOK N/A
- SOBR N/A
- EPS
- EVOK N/A
- SOBR N/A
- Revenue
- EVOK $12,794,859.00
- SOBR $301,400.00
- Revenue This Year
- EVOK $57.38
- SOBR N/A
- Revenue Next Year
- EVOK $59.57
- SOBR N/A
- P/E Ratio
- EVOK N/A
- SOBR N/A
- Revenue Growth
- EVOK 70.02
- SOBR 73.21
- 52 Week Low
- EVOK $1.94
- SOBR $2.41
- 52 Week High
- EVOK $12.32
- SOBR $193.50
- Technical
- Relative Strength Index (RSI)
- EVOK 49.82
- SOBR 44.34
- Support Level
- EVOK $5.00
- SOBR $3.08
- Resistance Level
- EVOK $5.27
- SOBR $3.31
- Average True Range (ATR)
- EVOK 0.22
- SOBR 0.20
- MACD
- EVOK -0.05
- SOBR 0.00
- Stochastic Oscillator
- EVOK 38.91
- SOBR 49.02
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.